Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Aktuell durch Fördergeber bewilligte Forschungsprojekte:

Tissue-Faktor-Aktivierung durch Gallensäuren in Hepatozyten *Wiedereinreichung
Projektleitung: Schlagenhauf Axel
Laufzeit: 07.01.2023 - 06.01.2026
Geldgeber: FWF, Fonds zur Förderung der Wissenschaftlichen Forschung

CDK9 Inhibition bei RAS-mutierter CMML
Projektleitung: Zebisch Armin
Laufzeit: 01.03.2023 - 28.02.2026
Geldgeber: FWF, Fonds zur Förderung der Wissenschaftlichen Forschung

> Weitere neue Projekte

Die aktuellsten Publikationen in "Top-Journalen" (Top 20 % Impact Ranking):

04.12.2022:

Margonis, GA; Boerner, T; Bachet, JB; Buettner, S; Moretto, R; Andreatos, N; Sartore-Bianchi, A; Wang, J; Kamphues, C; Gagniere, J; Lonardi, S; Løes, IM; Wagner, D; Spallanzani, A; Sasaki, K; Burkhart, R; Pietrantonio, F; Pikoulis, E; Pawlik, TM; Truant, S; Orlandi, A; Pikouli, A; Pella, N; Beyer, K; Poultsides, G; Seeliger, H; Aucejo, FN; Kornprat, P; Kaczirek, K; Lønning, PE; Kreis, ME; Wolfgang, CL; Weiss, MJ; Cremolini, C; Benoist, S; D'Angelica, M Demystifying BRAF Mutation Status in Colorectal Liver Metastases: A Multi-institutional, Collaborative Approach to 6 Open Clinical Questions.
Ann Surg. 2022; Doi: 10.1097/SLA.0000000000005771
PubMed FullText FullText_MUG

 

03.12.2022:

Niedermair, JF; Antipova, V; Manhal, S; Siwetz, M; Wimmer-Röll, M; Hammer, N; Fellner, FA On the added benefit of virtual anatomy for dissection-based skills.
Anat Sci Educ. 2022; Doi: 10.1002/ase.2234
PubMed FullText FullText_MUG

 

01.12.2022:

Hegen, H; Walde, J; Berek, K; Arrambide, G; Gnanapavan, S; Kaplan, B; Khalil, M; Saadeh, R; Teunissen, C; Tumani, H; Villar, LM; Willrich, MAV; Zetterberg, H; Deisenhammer, F Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: A systematic review and meta-analysis.
Mult Scler. 2022; 13524585221134213 Doi: 10.1177/13524585221134213
PubMed FullText FullText_MUG

 

29.11.2022:

Liebing, S; Dalkner, N; Ischebeck, A; Bengesser, SA; Birner, A; Fellendorf, FT; Lenger, M; Maget, A; Kroisenbrunner, H; Häussl, A; Platzer, M; Queissner, R; Schönthaler, EMD; Stross, T; Tmava-Berisha, A; Reininghaus, EZ A one-year view on the association of metabolic syndrome and cognitive function in bipolar disorder - Preliminary data.
J Affect Disord. 2022; Doi: 10.1016/j.jad.2022.11.067
PubMed FullText FullText_MUG

 

> Weitere aktuelle Publikationen in Top-Journals

Distribution of Med Uni Graz affiliated publications by field-normalized Journal Impact Factor (JIFnorm)

Med Uni Graz publications¹ were assigned quintiles according to the normalized² Clarivate’s Journal Impact Factor of the journal at the time of publication.

Proportional Distribution: The color-coded columns show the distribution by JIFnorm-quintiles, while the left vertical axis indicates the proportion relative to the total articles published in a given year. The red line shows the total number of articles published each year (right vertical axis).

Example 1: Around 40% of the over 500 articles with Med Uni Graz affiliation published in 2019 had a normalized JIF > 0.8 (QU1).
Example 2: The proportion of articles published in journals with a normalized JIF < 0.4 (QU4 and QU5) has remained under 20% since 2010.

Absolute Impact: The sum of the normalized JIFs for all published articles in a given year, color-coded according to the respective quintile.

¹ This analysis considered only publications categorized as full papers/original articles.

² IFnorm = (number of journals in WoS category - ranking of journal + 1) / number of journals in WoS category. An IFnorm of 0.8 means that 20% of the journals in this subject category have a higher IF than the respective journal. The highest possible IFnorm is 1, which means that this journal currently has the highest IF in this subject category.